It enhances ATP production, reduces oxidative stress, and supports cellular energy efficiency, making it a promising compound for performance, recovery, and anti-fatigue support
For instance, research shows MOTS-c drives glucose into the pentose phosphate pathway (for anabolic needs and antioxidant defense) rather than burning it immediately via glycolysis, while simultaneously increasing fatty-acid oxidation by upregulating carnitine shuttle activity in mitochondria
Thanks to the peptide's action, pain antagonism occurs, which is based on activity through the central dopaminergic system
With early-onset PD, bradykinesia and rigidity are more likely to be the presenting symptoms, rather than gait disturbance, when initially treated [1,37]